Literature DB >> 17468742

The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation.

Mamta Tahiliani1, Pinchao Mei, Rui Fang, Thiago Leonor, Michael Rutenberg, Fumiko Shimizu, Jing Li, Anjana Rao, Yujiang Shi.   

Abstract

Gene transcription is critically influenced by chromatin structure and the modification status of histone tails. Methylation of lysine residues in histone tails is dynamically regulated by the opposing activities of histone methyltransferases and histone demethylases. Here we show that JARID1C/SMCX, a JmjC-domain-containing protein implicated in X-linked mental retardation and epilepsy, possesses H3K4 tri-demethylase activity and functions as a transcriptional repressor. An SMCX complex isolated from HeLa cells contains additional chromatin modifiers (the histone deacetylases HDAC1 and HDAC2, and the histone H3K9 methyltransferase G9a) and the transcriptional repressor REST, suggesting a direct role for SMCX in chromatin dynamics and REST-mediated repression. Chromatin immunoprecipitation reveals that SMCX and REST co-occupy the neuron-restrictive silencing elements in the promoters of a subset of REST target genes. RNA-interference-mediated depletion of SMCX derepresses several of these targets and simultaneously increases H3K4 trimethylation at the sodium channel type 2A (SCN2A) and synapsin I (SYN1) promoters. We propose that loss of SMCX activity impairs REST-mediated neuronal gene regulation, thereby contributing to SMCX-associated X-linked mental retardation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17468742     DOI: 10.1038/nature05823

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  220 in total

Review 1.  Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2.

Authors:  Chiara Mozzetta; Julien Pontis; Slimane Ait-Si-Ali
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

2.  Eradicating the mediators of neuronal death with a fine-tooth comb.

Authors:  R Suzanne Zukin
Journal:  Sci Signal       Date:  2010-06-08       Impact factor: 8.192

3.  The JmjN domain of Jhd2 is important for its protein stability, and the plant homeodomain (PHD) finger mediates its chromatin association independent of H3K4 methylation.

Authors:  Fu Huang; Mahesh B Chandrasekharan; Yi-Chun Chen; Srividya Bhaskara; Scott W Hiebert; Zu-Wen Sun
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 4.  Epigenetics in nucleotide repeat expansion disorders.

Authors:  Fang He; Peter K Todd
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

Review 5.  Molecular mechanisms and potential functions of histone demethylases.

Authors:  Susanne Marije Kooistra; Kristian Helin
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

6.  PHF8 targets histone methylation and RNA polymerase II to activate transcription.

Authors:  Klaus Fortschegger; Petra de Graaf; Nikolay S Outchkourov; Frederik M A van Schaik; H T Marc Timmers; Ramin Shiekhattar
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

Review 7.  REST and CoREST are transcriptional and epigenetic regulators of seminal neural fate decisions.

Authors:  Irfan A Qureshi; Solen Gokhan; Mark F Mehler
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

8.  Profiling RE1/REST-mediated histone modifications in the human genome.

Authors:  Deyou Zheng; Keji Zhao; Mark F Mehler
Journal:  Genome Biol       Date:  2009-01-27       Impact factor: 13.583

9.  Histone demethylase RBP2 is critical for breast cancer progression and metastasis.

Authors:  Jian Cao; Zongzhi Liu; William K C Cheung; Minghui Zhao; Sophia Y Chen; Siew Wee Chan; Carmen J Booth; Don X Nguyen; Qin Yan
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

Review 10.  Developmental roles of the histone lysine demethylases.

Authors:  Amanda Nottke; Mónica P Colaiácovo; Yang Shi
Journal:  Development       Date:  2009-03       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.